Tech Company Financing Transactions

Biora Therapeutics Funding Round

On 12/18/2023, Biora Therapeutics raised $16.7 million in financing from Athyrium Capital Management, Davidson Kempner Capital Management LP and Highbridge Capital Management.

Transaction Overview

Company Name
Announced On
12/18/2023
Transaction Type
Debt
Venture Equity
Amount
$16,700,000
Round
Undisclosed
Proceeds Purpose
Biora is focused on development of two therapeutics platforms: the NaviCap� targeted oral delivery platform, which is designed to improve outcomes for patients with inflammatory bowel disease through treatment at the site of disease in the gastrointestinal tract, and the BioJet� systemic oral delivery platform, which is designed to replace injection for better management of chronic diseases through needle-free, oral delivery of large molecules.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4330 La Jolla Village Dr 300
San Diego, CA 92122
USA
Phone
Undisclosed
Email Address
Overview
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States.
Profile
Biora Therapeutics LinkedIn Company Profile
Social Media
Biora Therapeutics Company Twitter Account
Company News
Biora Therapeutics News
Facebook
Biora Therapeutics on Facebook
YouTube
Biora Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Adi Mohanty
  Adi Mohanty LinkedIn Profile  Adi Mohanty Twitter Account  Adi Mohanty News  Adi Mohanty on Facebook
Chief Financial Officer
Eric d'Esparbes
  Eric d'Esparbes LinkedIn Profile  Eric d'Esparbes Twitter Account  Eric d'Esparbes News  Eric d'Esparbes on Facebook
Chief Medical Officer
Ariella Kelman
  Ariella Kelman LinkedIn Profile  Ariella Kelman Twitter Account  Ariella Kelman News  Ariella Kelman on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/18/2023: Blue Planet venture capital transaction
Next: 12/18/2023: Greenfield Robotics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary